GF Fund Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$326K Hold
2,593
0.01% 283
2025
Q1
$287K Buy
2,593
+467
+22% +$51.7K 0.01% 291
2024
Q4
$290K Buy
+2,126
New +$290K 0.01% 258